$10.13+0.22 (+2.22%)
Abacus Global Management, Inc.
Abacus Global Management, Inc. in the Financial Services sector is trading at $10.13 with a market capitalization of $796M. Wall Street consensus targets $13.58 (6 analysts), implying a +34.1% move over the next 12 months. The stock is currently near its 52-week high of $10.54, remaining 28.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $59.39M↓ | $71.90M↑ | $62.98M↑ | $56.22M↑ | $44.14M |
| Gross Profit | $53.08M↓ | $63.86M↑ | $55.32M↑ | $50.17M↑ | $37.03M |
| Operating Income | $18.33M↓ | $22.80M↑ | $22.41M↓ | $22.79M↑ | $17.39M |
| Net Income | $7.27M↑ | $7.23M↑ | $7.08M↓ | $17.58M↑ | $4.64M |
Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States, Luxembourg, and internationally. The company operates in three segments: Asset Management, Life Solutions, and Technology Services segments...
Abacus Global Management, Inc. (ABX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how Abacus Global Management, Inc. (ABX) and ACNB (ACNB) have performed compared to their sector so far this year.
Abacus Global Management CEO Jay Jackson joined Steve Darling from Proactive to discuss the launch of LifeARC™, the company’s proprietary AI-powered lifespan modeling platform, and how it is being integrated into its broader wealth management strategy. Jackson explained that LifeARC™ leverages more than 20 years of proprietary data collected by Abacus to create personalized lifespan projections based on an individual’s medical history, health conditions, medications, genetics, and biometrics. Unlike traditional actuarial tables or population-based estimates, the platform continuously updates as a person's health profile changes, providing a dynamic model of expected longevity. The personalized lifespan model is designed to help improve financial planning by answering critical questions around retirement income, portfolio sustainability, healthcare costs, wealth preservation, and legacy planning. According to Jackson, understanding not just how much wealth a client has, but how long that wealth may need to last, can significantly improve financial decision-making. The discussion also highlighted Abacus’s recent investment of more than $50 million in wealth management firm Manning & Napier, which manages approximately $18 billion in assets and serves more than 3,400 clients. Jackson said the investment was driven by a strategic objective to bring LifeARC™ directly into client portfolios and financial planning conversations. By partnering with an established advisory platform, Abacus believes it can accelerate adoption of its technology while providing advisors with a unique tool that differentiates their services. Jackson noted that while many firms focus on projecting investment returns, LifeARC™ adds a new dimension by helping advisors estimate how long client assets may need to support retirement and future healthcare needs. The Manning & Napier partnership represents the first step in a broader strategy to expand LifeARC™ across the wealth management industry. Jackson indicated that discussions with other advisory firms are already underway as Abacus looks to establish lifespan-based financial planning as a new standard within the sector. Management believes the combination of artificial intelligence, proprietary health data, and financial planning expertise creates a powerful competitive advantage and positions LifeARC™ as a transformative tool for retirement and wealth management planning. #proactiveinvestors #abacusglobalmanagement #nasdaq #abl #EarningsBeat #FinancialGrowth #LifeSettlements #LifeARC #ArtificialIntelligence #WealthManagement #FinancialPlanning #Fintech #RetirementPlanning #AIFinance #ManningAndNapier #WealthTech
With an upside potential of 64.14%, Abacus Global Management, Inc. (NYSE:ABX) is among the 10 Best Insurance Stocks to Buy Following Q1 Earnings. On May 27, Abacus Global Management, Inc. (NYSE:ABX) and Manning & Napier announced the formation of a strategic alliance agreement alongside the completion of Abacus’s minority equity investment in Manning & Napier. Through the transaction, Abacus […]
Abacus Global Management (NYSE:ABX) has unveiled LifeARC, a proprietary AI-powered platform that generates personalized lifespan models for individuals using medical history, medications, genetics, and biometrics. The alternative asset manager said LifeARC draws on 20 years of proprietary...